posted on January 12, 2015

Several MSI PIs were featured in 10 most-viewed stories that appeared in the OVPR’s Inquiry blog during 2014. An article listing these stories can be found on the blog.

Stories that featured MSI PI research were highlighted on the MSI website. See:

MSI PIs Investigate Using Bacteria to Treat Diabetes (Inquiry story #1)

Early Disease Detection (Inquiry story #2)

Patent Awards to MSI PIs (Inquiry story #8)

posted on January 9, 2015

In December, Vice President for Research Brian Herman presented the annual state of University research report to the University Regents. The U’s research enterprise is strong, with growth in nearly all performance measures during FY14.

You can see VP Herman's summary of the report on the OVPR Inquiry blog. The article also includes a link to the complete report.


posted on January 6, 2015

The U’s Center for Sustainable Polymers (CSP) was featured in a video recently on the National Science Foundation’s Science Nation website. Two MSI Principal Investigators from the Center are featured in the video: Professor Marc Hillmyer (CSP Director; Chemistry) and Professor Chris Cramer (MSI Fellow; Chemistry). Researchers at the CSP are developing methods of using sustainable materials, rather than petroleum, to create plastics. Both Professors Hillmyer and Cramer use MSI to support their research in polymer chemistry.

Watch the video at the Science Nation website.

posted on January 5, 2015

On Wednesday, January 7, from 04:00 - 15:00, MSI staff will perform scheduled maintenance and upgrades to the network and various systems.

During this maintenance period, we will be performing the following updates:
• Panasas server software upgrade to 6.0.2
• Itasca system software upgrades and moab/torque upgrades
• Cascade system software upgrades and moab/torque upgrades
• Expressionist volume migration
• Galaxy volume migration/resizing

The Panasas update will result in a system-wide stall during the update process. Running jobs should simply pause until the Panasas systems return to service.

Systems status is always available on our Status page.

If you have any questions, please email

posted on December 16, 2014

Two MSI Principal Investigators, Associate Professor Reuben Harris (Biochemistry, Molecular Biology, and Biophysics) and Assistant Professor Daniel Harki (Medicinal Chemistry), have founded a start-up company that will create drug therapies for cancer treatment. ApoGen Biotechnologies, Inc. is developing a new class of drugs based on blocking the activity of the protein APOBEC, which is found in many cancer tumors. Both Professors Harris and Harki use MSI to support their research into APOBEC-family proteins.

An article about ApoGen Biotechnologies appeared recently on the OVPR’s Inquiry blog.